Cancer Australia supports cancer clinical trials in Australia in the following ways:
- Supports the 14 Multi-site Collaborative Cancer Clinical Trials Groups to develop investigator-initiated and industry-independent cancer clinical trials concepts and protocols.
- Funding National Technical Services to provide the trials groups with expert advice in health and pharmaco-economics and quality of life.
In 2024, over $22 million was awarded to support these groups until June 2027. The program contributes to the delivery of the Australian Cancer Plan through addressing unmet needs, improving trial design, and enhancing equitable access to cancer care, especially in rural and remote areas and Aboriginal and Torres Strait Islander communities.
From 2025-26, a further $3 million will be invested through this collaborative network to help set the shared foundation for integrating genomics into future cancer clinical trial protocols, progressing early implementation of the National Framework for Genomics in Cancer Control over the next 3 years.
Cancer Australia continues to steer the program as a core part of Australia’s national clinical trials infrastructure, ensuring it remains innovative, impactful and connected to global advances in cancer research.
